DK1309593T3 - Substituerede pyrazoler - Google Patents

Substituerede pyrazoler

Info

Publication number: DK1309593T3
Authority: DK; Denmark
Prior art keywords: substituted pyrazoles; methods; pyrazoles; substituted; cathepsin
Prior art date: 2000-08-14

Application number

DK01965898T

Other languages

English (en)

Inventor

Christopher R Butler

Darin J Gustin

Hui Cai

James P Edwards

Cheryl A Grice

Haripada Khatuya

Steven P Meduna

Barbara A Pio

Kevin L Tays

Jianmei Wei

Clark A Sehon

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-14

Filing date

2001-08-10

Publication date

2006-07-17

2001-08-10 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2006-07-17 Application granted granted Critical

2006-07-17 Publication of DK1309593T3 publication Critical patent/DK1309593T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

DK01965898T 2000-08-14 2001-08-10 Substituerede pyrazoler DK1309593T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22517800P	2000-08-14	2000-08-14
US09/927,324 US6953793B2 (en)	2000-08-14	2001-08-10	Substituted pyrazoles

Publications (1)

Publication Number	Publication Date
DK1309593T3 true DK1309593T3 (da)	2006-07-17

Family

ID=26919364

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01965898T DK1309593T3 (da)	2000-08-14	2001-08-10	Substituerede pyrazoler

Country Status (19)

Country	Link
US (2)	US6953793B2 (da)
EP (1)	EP1309593B1 (da)
JP (1)	JP5049447B2 (da)
KR (1)	KR100837193B1 (da)
AT (1)	ATE320427T1 (da)
AU (2)	AU2001286454B2 (da)
BR (1)	BRPI0113286B8 (da)
CA (1)	CA2419552C (da)
CZ (1)	CZ307185B6 (da)
DE (1)	DE60118004T2 (da)
DK (1)	DK1309593T3 (da)
ES (1)	ES2261463T3 (da)
HU (1)	HU230538B1 (da)
MX (1)	MXPA03001422A (da)
NZ (1)	NZ524191A (da)
PL (1)	PL213103B1 (da)
PT (1)	PT1309593E (da)
RU (1)	RU2317988C2 (da)
WO (1)	WO2002014315A2 (da)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6566372B1 (en) *	1999-08-27	2003-05-20	Ligand Pharmaceuticals Incorporated	Bicyclic androgen and progesterone receptor modulator compounds and methods
WO2002014314A2 (en) *	2000-08-14	2002-02-21	Ortho Mcneil Pharmaceutical, Inc.	Substituted pyrazoles
US20050101587A9 (en) *	2000-08-14	2005-05-12	Butler Christopher R.	Method for treating allergies using substituted pyrazoles
AU2001286454B2 (en) *	2000-08-14	2006-09-14	Ortho-Mcneil Pharmaceutical, Inc.	Substituted pyrazoles
US7064123B1 (en) *	2000-12-22	2006-06-20	Aventis Pharmaceuticals Inc.	Compounds and compositions as cathepsin inhibitors
JP4380992B2 (ja) *	2001-04-18	2009-12-09	ユーロ−セルティークエス．エイ．	ノシセプチン類似体
KR100878774B1 (ko) *	2001-04-18	2009-01-14	유로-셀티크 소시에떼 아노뉨	노시셉틴 유사체
US20040147503A1 (en) *	2002-06-04	2004-07-29	Sheila Zipfeil	Novel compounds and compositions as cathepsin inhibitors
NZ538961A (en)	2002-09-24	2008-02-29	Novartis Ag	Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
US7384970B2 (en)	2003-03-24	2008-06-10	Irm Llc	Inhibitors of cathepsin S
US7109243B2 (en)	2003-03-24	2006-09-19	Irm Llc	Inhibitors of cathepsin S
US7173051B2 (en)	2003-06-13	2007-02-06	Irm, Llc	Inhibitors of cathepsin S
US7256207B2 (en)	2003-08-20	2007-08-14	Irm Llc	Inhibitors of cathepsin S
FR2885904B1 (fr) *	2005-05-19	2007-07-06	Aventis Pharma Sa	Nouveaux derives du fluorene, compositions les contenant et utilisation
US7524845B2 (en) *	2005-06-22	2009-04-28	Chemocentryx, Inc.	Azaindazole compounds and methods of use
TW200813018A (en)	2006-06-09	2008-03-16	Astrazeneca Ab	Novel compounds
CL2007003590A1 (es) *	2006-12-12	2008-02-29	Wyeth Corp	Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt
US20090118274A1 (en) *	2007-02-15	2009-05-07	Darin Allen	Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080200454A1 (en) *	2007-02-15	2008-08-21	Ameriks Michael K	Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080207683A1 (en) *	2007-02-15	2008-08-28	Darin Allen	Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20090099157A1 (en) *	2007-02-15	2009-04-16	Ameriks Michael K	Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
US20080269241A1 (en) *	2007-02-15	2008-10-30	Darin Allen	Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US8119661B2 (en)	2007-09-11	2012-02-21	Astrazeneca Ab	Piperidine derivatives and their use as muscarinic receptor modulators
BRPI0914139A2 (pt)	2008-06-20	2015-10-20	Novartis Ag	composições pediátricas para o tratamento de esclerose múltipla
CN102186833A (zh) *	2008-08-18	2011-09-14	耶鲁大学	Mif调节剂
US9643922B2 (en)	2008-08-18	2017-05-09	Yale University	MIF modulators
US9540322B2 (en)	2008-08-18	2017-01-10	Yale University	MIF modulators
TWI475020B (zh) *	2009-03-12	2015-03-01		The substituted nicotine amide as a KCNQ2 / 3 modifier
CA2770904A1 (en) *	2009-08-12	2011-02-17	Jimmy T. Liang	Process for the preparation of cathepsin s inhibitors
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
UA125503C2 (uk)	2012-06-13	2022-04-13	Інсайт Холдинґс Корпорейшн	Заміщені трициклічні сполуки як інгібітори fgfr
WO2014026125A1 (en)	2012-08-10	2014-02-13	Incyte Corporation	Pyrazine derivatives as fgfr inhibitors
CN104955459B (zh)	2012-11-05	2019-02-01	南特知识产权控股有限责任公司	取代的吲哚-5-酚衍生物及其治疗应用
ES2625945T3 (es)	2012-11-14	2017-07-21	Glaxosmithkline Llc	Tieno[3,2-c]piridin-4(5H)-onas como inhibidores de bet
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
KR101871561B1 (ko)	2013-03-15	2018-06-27	난트바이오사이언스 인코포레이티드	치환된 인돌-5-올 유도체와 그들의 치료적 용도
WO2014172644A2 (en)	2013-04-19	2014-10-23	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
CN107001332B (zh) *	2014-12-02	2020-05-15	豪夫迈·罗氏有限公司	哌啶衍生物
US9580423B2 (en)	2015-02-20	2017-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
UA121669C2 (uk)	2015-02-20	2020-07-10	Інсайт Корпорейшн	Біциклічні гетероцикли як інгібітори fgfr
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
RS62639B1 (sr)	2015-07-06	2021-12-31	Alkermes Inc	Hetero-halo inhibitori histonskih deacetilaza
EP3319968A1 (en)	2015-07-06	2018-05-16	Rodin Therapeutics, Inc.	Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
TWI770104B (zh)	2017-01-11	2022-07-11	美商羅登醫療公司	組蛋白去乙醯酶雙環抑制劑
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
PL3664802T3 (pl)	2017-08-07	2022-07-11	Alkermes, Inc.	Bicykliczne inhibitory deacetylaz histonowych
CN111295094A (zh)	2017-10-09	2020-06-16	泰尔茂比司特生物技术有限公司	冻干容器及使用冻干容器的方法
CN112566912A (zh)	2018-05-04	2021-03-26	因赛特公司	Fgfr抑制剂的盐
SI3788047T1 (sl)	2018-05-04	2024-11-29	Incyte Corporation	Trdne oblike inhibitorja fgfr in postopki priprave le-teh
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
EP3938741B1 (en)	2019-03-14	2024-05-01	Terumo BCT Biotechnologies, LLC	Lyophilization container fill fixture, system and method of use
US11591329B2 (en)	2019-07-09	2023-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
US12122767B2 (en)	2019-10-01	2024-10-22	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
EP4045151A1 (en)	2019-10-14	2022-08-24	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en)	2019-10-16	2023-01-31	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
CA3163875A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
EP4069695A1 (en)	2019-12-04	2022-10-12	Incyte Corporation	Derivatives of an fgfr inhibitor
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
US12065494B2 (en)	2021-04-12	2024-08-20	Incyte Corporation	Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
WO2022261160A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
CA3220155A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US856514A (en) *	1907-03-15	1907-06-11	William T Adams	Cheese-cutter.
US3743409A (en)	1971-06-11	1973-07-03	Xerox Corp	Cutter assembly
JPS5090172A (da)	1973-12-13	1975-07-19
US3994890A (en)	1974-01-31	1976-11-30	Chugai Seiyaku Kabushiki Kaisha	1-Aminoalkyl, 3-phenyl indazoles
JPS5640714B2 (da) *	1974-03-04	1981-09-22
DK27383A (da)	1982-02-17	1983-08-18	Lepetit Spa	Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner
JPH0615542B2 (ja) *	1986-07-22	1994-03-02	吉富製薬株式会社	ピラゾロピリジン化合物
FR2642759B1 (fr)	1989-02-09	1991-05-17	Laboratorios Esteve Sa	Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2673628B1 (fr)	1991-03-07	1993-07-09	Esteve Labor Dr	Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
US5264576A (en)	1992-10-22	1993-11-23	Hoechst-Roussel Pharmaceuticals Incorporated	Pyrazolo[4,3-c]pyridines which are intermediates
FR2705962B1 (fr)	1993-06-03	1995-07-13	Rhone Poulenc Agrochimie	Arylpyrazoles fongicides.
RU2131876C1 (ru) *	1993-07-06	1999-06-20	Пфайзер Инк.	Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения
FR2712808B1 (fr)	1993-11-25	1996-02-16	Esteve Labor Dr	Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
IL112759A0 (en)	1994-02-25	1995-05-26	Khepri Pharmaceuticals Inc	Novel cysteine protease inhibitors
EP0817778A1 (en)	1995-03-24	1998-01-14	Arris Pharmaceutical Corporation	Reversible protease inhibitors
US5776718A (en)	1995-03-24	1998-07-07	Arris Pharmaceutical Corporation	Reversible protease inhibitors
TW438591B (en)	1995-06-07	2001-06-07	Arris Pharm Corp	Reversible cysteine protease inhibitors
FR2742052B1 (fr)	1995-12-12	1998-04-10	Esteve Labor Dr	Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
US6608030B1 (en)	1996-04-22	2003-08-19	Brigham & Women's Hospital, Inc.	Suppression of immune response via inhibition of cathepsin S
WO1998056785A1 (en) *	1997-06-12	1998-12-17	Sumitomo Pharmaceuticals Co., Ltd.	Pyrazole derivatives
PL202226B1 (pl)	1997-11-05	2009-06-30	Novartis Ag	Nitryl dipeptydowy, jego zastosowanie lecznicze i zawierająca go kompozycja farmaceutyczna
GB9806287D0 (en)	1998-03-24	1998-05-20	Synphar Lab Inc	Monobactam enzyme inhibitors
WO1999058153A1 (en)	1998-05-08	1999-11-18	Brigham & Women's Hospital	Methods of diagnosing and modulating autoimmunity
EP1155011A1 (en)	1999-02-20	2001-11-21	AstraZeneca AB	Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
JP2002538151A (ja)	1999-03-02	2002-11-12	ベーリンガーインゲルハイムファーマシューティカルズインコーポレイテッド	カテプシンの可逆的インヒビターとして有用な化合物
TW200404789A (en)	1999-03-15	2004-04-01	Axys Pharm Inc	Novel compounds and compositions as protease inhibitors
WO2001009110A1 (en)	1999-07-30	2001-02-08	Boehringer Ingelheim Pharmaceuticals, Inc.	Novel succinate derivative compounds useful as cysteine protease inhibitors
AU7490900A (en)	1999-09-16	2001-04-17	Axys Pharmaceuticals, Inc.	Chemical compounds and compositions and their use as cathepsin s inhibitors
EP1234821A4 (en)	1999-12-03	2002-10-28	Ono Pharmaceutical Co	1,3,4-OXADIAZOLINE DERIVATIVES AND MEDICINES THAT CONTAIN THEIR ACTIVE SUBSTANCE
AU2001286454B2 (en) *	2000-08-14	2006-09-14	Ortho-Mcneil Pharmaceutical, Inc.	Substituted pyrazoles

2001
- 2001-08-10 AU AU2001286454A patent/AU2001286454B2/en not_active Expired
- 2001-08-10 EP EP01965898A patent/EP1309593B1/en not_active Expired - Lifetime
- 2001-08-10 JP JP2002519455A patent/JP5049447B2/ja not_active Expired - Lifetime
- 2001-08-10 PL PL360696A patent/PL213103B1/pl unknown
- 2001-08-10 ES ES01965898T patent/ES2261463T3/es not_active Expired - Lifetime
- 2001-08-10 CA CA2419552A patent/CA2419552C/en not_active Expired - Lifetime
- 2001-08-10 AT AT01965898T patent/ATE320427T1/de active
- 2001-08-10 KR KR1020037002163A patent/KR100837193B1/ko not_active Expired - Lifetime
- 2001-08-10 NZ NZ524191A patent/NZ524191A/en not_active IP Right Cessation
- 2001-08-10 AU AU8645401A patent/AU8645401A/xx active Pending
- 2001-08-10 CZ CZ2003-429A patent/CZ307185B6/cs not_active IP Right Cessation
- 2001-08-10 MX MXPA03001422A patent/MXPA03001422A/es active IP Right Grant
- 2001-08-10 PT PT01965898T patent/PT1309593E/pt unknown
- 2001-08-10 BR BRPI0113286A patent/BRPI0113286B8/pt not_active IP Right Cessation
- 2001-08-10 RU RU2003107016/04A patent/RU2317988C2/ru not_active Application Discontinuation
- 2001-08-10 US US09/927,324 patent/US6953793B2/en not_active Expired - Lifetime
- 2001-08-10 DK DK01965898T patent/DK1309593T3/da active
- 2001-08-10 WO PCT/US2001/025290 patent/WO2002014315A2/en not_active Ceased
- 2001-08-10 DE DE60118004T patent/DE60118004T2/de not_active Expired - Lifetime
- 2001-08-10 HU HU0303108A patent/HU230538B1/hu not_active IP Right Cessation
2005
- 2005-06-30 US US11/174,077 patent/US20050245576A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2003107016A (ru)	2004-11-27
HUP0303108A2 (hu)	2004-01-28
KR100837193B1 (ko)	2008-06-13
AU8645401A (en)	2002-02-25
US20030078419A1 (en)	2003-04-24
WO2002014315A3 (en)	2002-06-13
ATE320427T1 (de)	2006-04-15
DE60118004T2 (de)	2006-11-16
RU2317988C2 (ru)	2008-02-27
BRPI0113286B8 (pt)	2021-05-25
MXPA03001422A (es)	2004-01-26
PL360696A1 (en)	2004-09-20
CZ2003429A3 (cs)	2003-12-17
CZ307185B6 (cs)	2018-03-07
NZ524191A (en)	2004-11-26
PT1309593E (pt)	2006-08-31
KR20030060876A (ko)	2003-07-16
WO2002014315A2 (en)	2002-02-21
HUP0303108A3 (en)	2012-10-29
JP5049447B2 (ja)	2012-10-17
AU2001286454B2 (en)	2006-09-14
BR0113286A (pt)	2003-09-09
BR0113286B1 (pt)	2013-04-16
HU230538B1 (hu)	2016-11-28
PL213103B1 (pl)	2013-01-31
CA2419552C (en)	2010-10-12
JP2004511440A (ja)	2004-04-15
ES2261463T3 (es)	2006-11-16
US6953793B2 (en)	2005-10-11
CA2419552A1 (en)	2002-02-21
DE60118004D1 (de)	2006-05-11
US20050245576A1 (en)	2005-11-03
EP1309593B1 (en)	2006-03-15
HK1055422A1 (en)	2004-01-09
EP1309593A2 (en)	2003-05-14

Publication	Publication Date	Title
DK1309593T3 (da)	2006-07-17	Substituerede pyrazoler
DK1309592T3 (da)	2006-08-21	Substituerede pyrazoler
WO2002014314A3 (en)	2002-06-06	Substituted pyrazoles
NO20030845D0 (no)	2003-02-24	Utvalgte fusjonerte pyrrolokarbazoler
BG66084B1 (bg)	2011-03-31	Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
BG66080B1 (bg)	2011-03-31	Заместени тиоацетамиди
NO991732L (no)	1999-06-04	Nye heterocyklylmetylsubstituerte pyrazolderivater
DE60021381D1 (de)	2005-08-25	Chinonverbindungen zur behandlung von krankheiten
MY158159A (en)	2016-09-15	Novel fused pyrrolocarbazoles
SG149042A1 (en)	2009-01-29	Novel fused pyrrolocarbazoles
TR200402030T4 (tr)	2004-09-21	İkame edilen I-aminobutan-3-ol-türevleri
DK1438034T3 (da)	2008-12-01	Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
ATE247130T1 (de)	2003-08-15	Inhibitoren für den urokinaserezeptor
UA87829C2 (en)	2009-08-25	Fused pyrrolocarbazoles
CY1111290T1 (el)	2015-08-05	Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
ATE423780T1 (de)	2009-03-15	Makrozyclen zur behandlung von krebserkrankungen
SE0001631D0 (sv)	2000-05-04	New use
BR0111221A (pt)	2003-03-18	Condensados glioxal-fenólicos com fluorescência intensificada